How Centene Cost Issues Show Future Glimpse Into Trump's Medicaid Cuts
The problems Centene appears to be having managing the costs of low-income Americans covered by Medicaid and individual plans under the Affordable Care Act could only be the beginning of what's to come for more health insurers.
Centene last week pulled its financial forecast for the rest of this year after an outside firm's review of data that showed subscribers in its ACA plans are sicker and need more care than the company anticipated. In addition, Centene is also seeing higher cost trends in its Medicaid business -- coverage for low-income Americans the insurer helps more than two dozen states manage.
In the future, the management of Medicaid patients may get even trickier for health insurers after President Donald Trump last week signed into law legislation that cuts $1 trillion from Medicaid and ACA plans that is expected to eliminate coverage for nearly 12 million Americans over the next decade, data from the Congressional Budget Office shows.
Analysts expect health insurers to find it more difficult to keep Americans signed up for Medicaid and ACA plans because the Trump-approved bill requires more eligibility checks and bureaucratic hurdles. These eligibility checks in the Medicaid program are called 'redeterminations' and they are already to blame for millions of Americans falling off of Medicaid coverage following the end of the Covid-19 pandemic in 2023.
'Due to new red tape and barriers to enrollment and re-enrollment, people losing eligibility for Medicaid will find an individual market with less choice and higher premiums,' the trade group and lobby America's Health Insurance Plans (AHIP) said. AHIP represents some of the biggest providers of individual coverage including Centene, Oscar Health, Elevance Health, Cigna and an array of Blue Cross and Blue Shield plans.
In the individual market, millions more Americans face the possibility of losing coverage because the legislation written by Republicans in Congress doesn't extend tax credits signed into law by former President Joe Biden beyond this year. As the bill Trump signed into law takes effect, the reduced spending on these tax credits, or subsidies, means buyers of ACA plans will face higher premiums and out-of-pocket costs.
In Centene's case, the actuarial firm Wakely found subscribers to ACA plans, also known as Obamacare, were sicker and needed more healthcare services that what the company planned for.
'We believe a key issue could be a structural shift in the cost profile of the (ACA health insurance exchange) population due to Medicaid Redeterminations,' Ann Hynes and colleagues at Mizuho Securities USA wrote in a report last week. 'We would not be buyers on weakness and look for increased clarity on Centene's ability to reprice (health insurance exchange plans) for 2026 and increased visibility on the extent of Medicaid (medical loss ratio) pressures.'
Analysts see sicker patients buying health plans while healthier people will go without, leaving the risk pools filled with those needing more services, costing health insurers even more. Mizuho's Hynes is already hinting Centene will 'reprice' its 2026 plans and they will be more expensive for buyers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
22 minutes ago
- New York Times
Veterans Affairs Dept. Scales Back Plans for Vast Job Cuts
The Department of Veterans Affairs has scaled back its effort to reduce its work force by more than 80,000 people, saying on Monday that it intended to cut nearly 30,000 jobs by the end of September instead. The department effectively abandoned its previous plan to fire tens of thousands of workers as part of President Trump's wide-reaching plan to slash the federal bureaucracy. The new target, outlined in a department news release, would slash a work force that numbered 484,000 earlier this year to about 455,000. Nearly 17,000 employees have already left. Instead of firing workers, the rest of the cuts would be made by offering early retirement or severance payments, along with what the department described as 'normal attrition' — the small percentage of employees who quit or move to other jobs every year. 'A departmentwide R.I.F. is off the table,' said Doug Collins, the veterans affairs secretary, referring to a reduction in force, the formal process to initiate mass layoffs in the agency. 'As a result of our efforts, V.A. is headed in the right direction — both in terms of staff levels and customer service,' he said. The department, which provides health care for military veterans, had previously insisted that job cuts would not affect services, and said again on Monday that it had 'multiple safeguards in place' to prevent disruptions. A law signed by President Joseph R. Biden Jr. had significantly expanded the veterans benefits system and set off a record-breaking hiring spree at the department. The department said on Monday that it had continued to cut a backlog of benefits claims after a spike during the Biden administration. In addition to its primary mission of providing care to veterans and serving as the nation's backup health care system, the department also oversees some medical research and manages veterans benefits programs — like pensions, banking, home loans, insurance, job training and funding for college degrees.
Yahoo
24 minutes ago
- Yahoo
Apple is still trying to overturn the ban on the Apple Watch blood oxygen sensor
Apple is making another attempt to appeal the trade ban that forced it to remove the blood oxygen sensor from its smartwatches, Reuters reports. The company was forced to remove the feature in 2024, following a decision from the International Trade Commission (ITC) in 2023 that banned sales of the Apple Watch for violating health tech startup Masimo's patents. The US Court of Appeals for the Federal Circuit heard new arguments from Apple and Masimo's lawyers on Monday over the legality of the original ITC ban. Apple's argument is that the fact Masimo was developing its own smartwatch when Apple released the Apple Watch Series 6 in 2020 — the first of the company's wearables with a blood oxygen sensor — shouldn't be enough to justify the ban. Masimo disagrees. The appeals court has heard the company's arguments before, and even briefly paused the trade ban in December 2023 while the ITC considered Apple's request for a longer pause. Ultimately, the ITC ruled in Masimo's favor and denied Apple's request. Apple removed the blood oxygen sensor in 2024 so it could restart sales of the Apple Watch Series 9 and Apple Watch Ultra 2 in the US. The companies' fight goes beyond just the blood oxygen sensor — Masimo's smartwatches were, ironically, found to infringe on Apple patents — but clearly Apple is hung up on the feature. The company's blood oxygen sensor was never as accurate as the pulse oximeters used in a doctor's office, but it was part of a fairly comprehensive suite of heart health features on the smartwatch. It's entirely possible Apple wants to reintroduce it in its watches as part of an even more ambitious health feature down the road.
Yahoo
37 minutes ago
- Yahoo
The doctor fighting for women's health on Ukraine's front line
In a rural village close to the Ukrainian front line, a group of women queue quietly outside a purple and white ambulance, waiting to be seen by a doctor with his shaved head dyed the blue and yellow of the Ukrainian flag. For many of them, it's their first time seeing a doctor since the war began more than three years ago. Since 2022, Dr Serhii Baksheiev, 53, has carried out more than 1,000 gynaecological examinations on women throughout front-line and occupied areas in his kitted out mobile clinic - named 'The Feminine Shuttle' and complete with a bright pink examination chair. "This is a humanitarian volunteering mission. It's for people who need help, in places where there are no doctors or hospitals, and it's absolutely free," he says. The war with Russia has placed a huge strain on Ukraine's healthcare system, with more than 1,940 attacks on health facilities since the invasion, according to the World Health Organization (WHO) - making it the highest number in any humanitarian crisis to date - and with a significant increase in those attacks since December 2023. When the war began, Dr Baksheiev, who is an obstetrician and gynaecologist, initially spent his days in a bunker in Kyiv helping to deliver babies as bombs fell above. 'They took shrapnel from my heart' – the magnets saving lives in Ukraine 'It's Groundhog Day': Ukraine's sky defenders stuck in relentless battle The idea for an on-the-road clinic came to him, he says, after later medical volunteer missions to the front line revealed the lack of facilities because medical centres and hospitals had been completely destroyed. "We went to Kharkiv and Chernihiv, which were very damaged, and the most difficult thing was not being able to provide gynaecological services because there were no tools and equipment, because everything was ruined," he says. Dr Baksheiev and his team would have to use anything available as an examination table, including old sofas, meaning he would have to kneel on the floor to conduct examinations. Today, walking around the electric vehicle, it's clear Dr Baksheiev is incredibly proud of its capabilities: it's been kitted out with everything he and his team could need in these remote areas, including an ultrasound machine and medical equipment to carry out minor surgeries. During a two-day mission the team can perform up to 80 colposcopies - where they examine the cervix and vulva for signs of cancerous or pre-cancerous tissue. The work is crucial to the people living in these remote areas. His visits to small rural villages occupied by the Russians are often carried out in secret. He and his team slip in for a day or two to carry out their examinations and leave before they are detected. Figures provided by Ukraine's public health ministry and seen by the BBC show detection rates for ovarian and cervical cancers are down by 17% and 10% respectively since 2020. And when doctors like Dr Baksheiev do get into those areas to perform examinations, they are finding a higher than average incidence of malignant tumours. On average, up to 4% of all women are diagnosed with malignant tumours after being examined, according to FRIDA Ukraine, the medical organisation Dr Baksheiev volunteers for. Dr Ulana Supron was Ukraine's health minister from 2016 to 2019. She says there is a concern about the "ticking time bomb" of health outcomes as the war drags on. "In the public health community, there definitely is a lot of worry about what's going to happen as the war continues," she says. "Not only in terms of physical health, but also mental health - because there is a constant stress, constant psychological trauma happening." Dr Supron says the government has managed to partially or fully rebuild as many as 964 medical facilities that were damaged by Russia. "They're working closely with the WHO and with other international organisations to try to come up with a plan on how we can rebuild the health system that was in place prior to Russia's invasion," she adds. Despite a cancer diagnosis himself in September 2024, Dr Baksheiev continues to volunteer and provide treatment to women across the country. "Apart from the medical examination, you also hear them out because a lot of patients have stories about how the Russians attacked their villages," he says. "So we are not only doctors, we're the therapists for these patients."
